These inhibitors should then be integrated with targeted protein degradation technologies such as PROTACs, molecular glues, or PROTAC-DUB chimeras to achieve rapid, reversible, and tumor-specific depletion of USP enzymes. Here, ZUP1 is linked to neoplasm.